Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sunshine Biopharma (SBFM) Asset Utilization Ratio: 2016-2024

Historic Asset Utilization Ratio for Sunshine Biopharma (SBFM) over the last 9 years, with Dec 2024 value amounting to 1.20.

  • Sunshine Biopharma's Asset Utilization Ratio rose 5.93% to 1.18 in Q3 2025 from the same period last year, while for Sep 2025 it was 1.18, marking a year-over-year increase of 5.93%. This contributed to the annual value of 1.20 for FY2024, which is 41.46% up from last year.
  • As of FY2024, Sunshine Biopharma's Asset Utilization Ratio stood at 1.20, which was up 41.46% from 0.85 recorded in FY2023.
  • Sunshine Biopharma's 5-year Asset Utilization Ratio high stood at 1.20 for FY2024, and its period low was 0.12 during FY2020.
  • For the 3-year period, Sunshine Biopharma's Asset Utilization Ratio averaged around 0.78, with its median value being 0.85 (2023).
  • Data for Sunshine Biopharma's Asset Utilization Ratio shows a peak YoY spiked of 267.99% (in 2020) over the last 5 years.
  • Yearly analysis of 5 years shows Sunshine Biopharma's Asset Utilization Ratio stood at 0.12 in 2020, then rose by 12.62% to 0.14 in 2021, then skyrocketed by 96.51% to 0.28 in 2022, then soared by 208.08% to 0.85 in 2023, then soared by 41.46% to 1.20 in 2024.